First quarter expenses more than doubled at Sienna Biopharmaceuticals

You are here: Home > Central Coast Health Watch > Current Article

First quarter expenses more than doubled at Sienna Biopharmaceuticals

By Staff Report / Monday, May 14th, 2018 / Comments Off on First quarter expenses more than doubled at Sienna Biopharmaceuticals

Operating expenses for Westlake Village-based Sienna Biopharmaceuticals more than doubled for the first quarter to $18.5 million as it launched a third product into clinical trials. The pre-revenue company said net loss came to $17.1 million, or 85 cents per share, and it burned through $14.5 million for the quarter ended March 31, leaving it…

This article is only available to Business Times subscribers

Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
Check the STATUS of your Subscription Account.